Latest Videos |view all videos
Mayo Clinic is announcing the first stem cell clinical trial for pediatric congenital heart disease in the U.S. The trial aims to determine how stem cells from autologous umbilical cord blood can help children with hypoplastic left heart syndrome (HLHS).
Steve R. Ommen, M.D., and Raul E. Espinosa, M.D., weigh in on the interaction of the tricuspid valve prosthesis with pacemakers and defibrillators.
Charanjit S. Rihal, M.D., and Stephen L. Kopecky, M.D., discuss erectile dysfunction and its impact on cardiovascular prognosis and diagnosis.
Bernard Gersh, M.B., Ch.B., D.Phil., and R. Scott Wright, M.D., examine the introduction of interventional lipidology and other lipid-lowering strategies as in comparison to preventive cardio.
Bernard J. Gersh, M.B., Ch.B., D.Phil., and Randal J. Thomas, M.D., discuss the UPBEAT study and other data on exercise and depression in peoplewith CAD.
Charanjit (Chet) Rihal, MD, MBA, interviews Paul Sorajja, MD, about appropriate approaches to managing and evaluating hypertrophic cardiomyopathy.
Joseph A. Murray, MD, and Charanjit (Chet) Rihal, MD, MBA, discuss the differentiation between symptoms from celiac disease versus a medication, olmesartan.
Ray W. Squires, Ph.D., and Steve R. Ommen, M.D., weigh the potential risks and benefits of the hot topic of high-intensity interval training in treatment of cardiovascular disease.
Mary Pyfferoen, P.T., of Mayo Clinic, discussed her AAPMR poster presentation, titled "Inpatient Rehabilitation in Patients Receiving Left Ventricular Assist Device Therapy."